Biogen reported $52.13B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acorda Therapeutics ACOR:US $ 45.26M 955.08K
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
ALKERMES ALKS:US 3.93B 959.72M
Amgen AMGN:US $ 140.05B 3.22B
Bayer BAYN:GR 50.48B 2.53B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Eli Lilly And LLY:US $ 220.12B 40.96B
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Gilead Sciences GILD:US $ 86.36B 4.99B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Intra Cellular Therapies ITCI:US $ 3.32B 573.64M
Marinus Pharmaceuticals MRNS:US $ 657.2M 90.12M
Merk MRK:US $ 196918.18M 1780.24M
Moderna Inc MRNA:US $ 94.35B 41.95B
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NOVN:VX 208.02B 8.76B
Pfizer PFE:US $ 219205.69M 17108.81M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Sanofi SNY:US 132.07B 7.67B
Sanofi SAN:FP 111.4B 5.33B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Seattle Genetics SGEN:US $ 28.65B 3.48B
Teva Pharmaceutical TEVA:IT 35.79B 6.09B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
United Therapeutics UTHR:US $ 8.04B 550.55M
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
YTE INCY:US $ 18.5B 632.77M